The Centre offers:

• A track record in Public Private Partnerships and delivery of translational projects

• Laboratory facilities including Category 3 laboratories, medicinal chemistry laboratories, analytical laboratories, robotic liquid handling and high content imaging platforms

• Access to Hazard Group 3 human pathogens, e.g. Mycobacterium tuberculosis and Plasmodium falciparum

• Access to in vitro and in vivo models of infection

• Access to patient populations and pathways to drug and diagnostic evaluation and implementation in the UK, Africa, Asia and South America

• Field sites for monitoring and evaluation in Africa, South America, South-East Asia

• Links to policy makers such as WHO and advisory committees and funders

• Training of laboratory staff